More than half of patients pres­cribed dual antiplatelet therapy for coronary artery disease remain on the drugs longer than the recommended 12 months, researchers have found in a Queensland cohort.

They also showed that, despite expectations that the burden of medical therapy would be reduced following stent insertion, this did not occur in practice.